These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15819285)

  • 1. Risk of anaphylaxis after reexposure to intravenous lepirudin in patients with current or past heparin-induced thrombocytopenia.
    Cardenas GA; Deitcher SR
    Mayo Clin Proc; 2005 Apr; 80(4):491-3. PubMed ID: 15819285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.
    Badger NO; Butler K; Hallman LC
    Pharmacotherapy; 2004 Dec; 24(12):1800-3. PubMed ID: 15585446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe anaphylactic reaction after repeated intermittent exposure to lepirudin.
    Veach SA; Franks AM; Allan MC
    Pharmacotherapy; 2007 May; 27(5):760-5. PubMed ID: 17461712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies.
    Lubenow N; Eichler P; Lietz T; Farner B; Greinacher A
    Blood; 2004 Nov; 104(10):3072-7. PubMed ID: 15280202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended and actual lepirudin doses in patients with renal insufficiency.
    Saxer SB; Smith BS; Gandhi PJ; Tataronis GR; Krikorian SA
    Am J Health Syst Pharm; 2003 Dec; 60(24):2588-93. PubMed ID: 14735776
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosage of lepirudin in renal failure.
    Shepherd MF
    Am J Health Syst Pharm; 2002 Jan; 59(1):77-8. PubMed ID: 11813471
    [No Abstract]   [Full Text] [Related]  

  • 8. Lepirudin in the management of heparin-induced thrombocytopenia.
    Gajra A; Husain J; Smith A
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients.
    Tschudi M; Lämmle B; Alberio L
    Blood; 2009 Mar; 113(11):2402-9. PubMed ID: 19059879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
    Dager WE; White RH
    Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
    Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.
    Greinacher A; Eichler P; Lubenow N; Kwasny H; Luz M
    Blood; 2000 Aug; 96(3):846-51. PubMed ID: 10910895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 15. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
    Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
    J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration.
    Jappe U; Reinhold D; Bonnekoh B
    Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced thrombocytopenia type II. Intra- and postoperative lepirudin treatment in acute ischemia of the extremities].
    Schmidt O; Lang W
    Dtsch Med Wochenschr; 1998 Oct; 123(41):1207-10. PubMed ID: 9810286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.